Subscribe To

Price Alert Latest News Economic Calendar News

LMNL / Liminal BioSciences stock rockets on take-private deal with a fund managed by Thomvest Asset Management

Liminal BioSciences Inc. LMNL, -1.33% stock is rallying 41.7% in premarket trades on Wednesday after the company said it agreed to go private at a price of $8.50 a share. Structured Alpha LP, a fund managed by Thomvest Asset Management Ltd. Read More

Demo Live Account See Partner Details

Content Topics

Liminal

Biosciences

Stock

Rockets

Take

Private

Deal

With

Take private

Managed

Thomvest

Management

LMNL

Posted: Jul 12 2023, 07:48

Author Name: Market Watch

LMNL News

By Zacks Investment Research
July 13, 2023

Liminal (LMNL) Up 40% on Buyout Offer From Majority Shareholder

If the minority shareholders of Liminal BioSciences (LMNL) accept the buyout offer, they will receive $8.50 per share. This offer is a dollar more tha

By Market Watch
July 12, 2023

Liminal BioSciences stock rockets on take-private deal with a fund managed by Thomvest Asset Management

Liminal BioSciences Inc. LMNL, -1.33% stock is rallying 41.7% in premarket trades on Wednesday after the company said it agreed to go private at a pri

By InvestorPlace
April 5, 2023

Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?

Liminal Biosciences (NASDAQ: LMNL ) stock is taking off on Wednesday as investors react to the biopharmaceutical company getting an unsolicited transa

By Market Watch
April 5, 2023

Liminal Biosciences' stock soars 91% after getting takeover offer that's more than double its price

Liminal Biosciences Inc.'s stock LMNL, -4.23% soared 91% in premarket trade Wednesday, after the company said it's received an unsolicited takeover of

By Seeking Alpha
March 17, 2023

Liminal BioSciences Inc. (LMNL) Q4 2022 Earnings Call Transcript

Liminal BioSciences Inc. (NASDAQ:LMNL ) Q4 2022 Results Conference Call March 16, 2023 8:30 AM ET Company Participants Shrinal Inamdar - IR Bruce Prit

By PRNewsWire
January 19, 2023

Liminal BioSciences to Present at BIO CEO & Investor Conference

LAVAL, QC and CAMBRIDGE, England , Jan. 19, 2023 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), ann

By Seeking Alpha
November 13, 2022

Liminal Biosciences (LMNL) Q3 2022 Earnings Call Transcript

Liminal Biosciences (NASDAQ:LMNL ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Shrinal Inamdar - Investor Relat

By Seeking Alpha
May 13, 2022

Liminal BioSciences Inc. (LMNL) CEO Bruce Pritchard on Q1 2022 Results - Earnings Call Transcript

Liminal BioSciences Inc. (NASDAQ:LMNL ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Shrinal Inamdar - Investor Relat

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.